Search research articles
Contact Us
Filters
Showing results (161-170 of 193) with videos related to
Page
of 20
Sort By:
European Journal of Pharmacology
|
May 2, 1980
Effect of vasoactive intestinal peptide (VIP) on somatostatin inhibition of pituitary growth hormone secretion in vitro
L Tapia-Arancibia, S Arancibia, M T Bluet-Pajot, et al.
Annales D'Endocrinologie
|
February 23, 2008
[Clinical and genetic aspects of combined pituitary hormone deficiencies]
F Castinetti, R Reynaud, A Saveanu, et al.
Biochemical and Biophysical Research Communications
|
March 31, 1992
Effect of an essential fatty acid deficiency on the phospholipid composition in anterior pituitary membranes
M L Alessio, D E Wandscheer, M C Soares, et al.
Hormone Research
|
January 1, 1992
Resistance to somatostatin (SRIH) analog therapy in acromegaly. Re-evaluation of the correlation between the SRIH receptor status of the pituitary tumor and the in vivo inhibition of GH secretion in response to SRIH analog
J Bertherat, P Chanson, D Dewailly, et al.
Neuroendocrinology
|
September 1, 1994
Decreased expression of the two D2 dopamine receptor isoforms in bromocriptine-resistant prolactinomas
L Caccavelli, F Feron, I Morange, et al.
Annales D'Endocrinologie
|
September 6, 2000
[Pituitary development and pathology of transcription factors]
A Barlier, S Vallette-Kasic, M Manavela, et al.
Molecular Endocrinology (Baltimore, Md.)
|
February 27, 2001
Combined pituitary hormone deficiency due to the F135C human Pit-1 (pituitary-specific factor 1) gene mutation: functional and structural correlates
S Vallette-Kasic, I Pellegrini-Bouiller, F Sampieri, et al.
The Journal of Clinical Endocrinology and Metabolism
|
May 20, 1998
Pronostic and therapeutic consequences of Gs alpha mutations in somatotroph adenomas
A Barlier, G Gunz, A J Zamora, et al.
The Journal of Clinical Endocrinology and Metabolism
|
December 6, 2002
Demonstration of enhanced potency of a chimeric somatostatin-dopamine molecule, BIM-23A387, in suppressing growth hormone and prolactin secretion from human pituitary somatotroph adenoma cells
A Saveanu, E Lavaque, G Gunz, et al.
The Journal of Clinical Endocrinology and Metabolism
|
August 1, 1996
A new mutation of the gene encoding the transcription factor Pit-1 is responsible for combined pituitary hormone deficiency
I Pellegrini-Bouiller, P Bélicar, A Barlier, et al.
Page
of 20
Search research articles
Search
Showing results (161-170 of 193) with videos related to
Sort By:
Page
of 20
European Journal of Pharmacology
|
May 2, 1980
Effect of vasoactive intestinal peptide (VIP) on somatostatin inhibition of pituitary growth hormone secretion in vitro
L Tapia-Arancibia, S Arancibia, M T Bluet-Pajot, et al.
Annales D'Endocrinologie
|
February 23, 2008
[Clinical and genetic aspects of combined pituitary hormone deficiencies]
F Castinetti, R Reynaud, A Saveanu, et al.
Biochemical and Biophysical Research Communications
|
March 31, 1992
Effect of an essential fatty acid deficiency on the phospholipid composition in anterior pituitary membranes
M L Alessio, D E Wandscheer, M C Soares, et al.
Hormone Research
|
January 1, 1992
Resistance to somatostatin (SRIH) analog therapy in acromegaly. Re-evaluation of the correlation between the SRIH receptor status of the pituitary tumor and the in vivo inhibition of GH secretion in response to SRIH analog
J Bertherat, P Chanson, D Dewailly, et al.
Neuroendocrinology
|
September 1, 1994
Decreased expression of the two D2 dopamine receptor isoforms in bromocriptine-resistant prolactinomas
L Caccavelli, F Feron, I Morange, et al.
Annales D'Endocrinologie
|
September 6, 2000
[Pituitary development and pathology of transcription factors]
A Barlier, S Vallette-Kasic, M Manavela, et al.
Molecular Endocrinology (Baltimore, Md.)
|
February 27, 2001
Combined pituitary hormone deficiency due to the F135C human Pit-1 (pituitary-specific factor 1) gene mutation: functional and structural correlates
S Vallette-Kasic, I Pellegrini-Bouiller, F Sampieri, et al.
The Journal of Clinical Endocrinology and Metabolism
|
May 20, 1998
Pronostic and therapeutic consequences of Gs alpha mutations in somatotroph adenomas
A Barlier, G Gunz, A J Zamora, et al.
The Journal of Clinical Endocrinology and Metabolism
|
December 6, 2002
Demonstration of enhanced potency of a chimeric somatostatin-dopamine molecule, BIM-23A387, in suppressing growth hormone and prolactin secretion from human pituitary somatotroph adenoma cells
A Saveanu, E Lavaque, G Gunz, et al.
The Journal of Clinical Endocrinology and Metabolism
|
August 1, 1996
A new mutation of the gene encoding the transcription factor Pit-1 is responsible for combined pituitary hormone deficiency
I Pellegrini-Bouiller, P Bélicar, A Barlier, et al.
Page
of 20